February 20, 2013
CONNECT WITH SMARTBRIEF LinkedInFacebookTwitterGoogle+Email
News for the pain professional

Pain Research News
Researchers look for biologic causes of plantar fasciitis
Researchers agree on a basic definition of plantar fasciitis but not on the biological mechanisms involved, including the role played by inflammation in the condition. Biopsies have indicated that chronic plantar fasciitis may not be linked with inflammation, and researchers are looking at whether it is caused by degeneration or weakening of tissues in the foot. The New York Times (tiered subscription model) (2/20)
Fibromyalgia is not a clear-cut diagnosis, study finds
Evidence shows fibromyalgia is not a clear-cut disorder but includes symptoms ranging from none to severe across patient populations, according to a study in Arthritis Care & Research. "In those with fibromyalgia there is overwhelming polysymptomatic distress, with severe pain and severe symptoms of all sorts," said Dr. Frederick Wolfe of the National Data Bank for Rheumatic Diseases. MedPage Today (free registration) (2/19)
Treatment News
Patients report unexpectedly high post-procedure pain
Patients have higher-than-expected levels of post-operative pain for simple surgeries such as appendectomy, tonsillectomy and laparoscopic procedures, according to a study in the journal Anesthesiology. Researchers from Denmark and the University of Texas Southwestern Medical School commented that the reason may be that patients undergoing operations perceived to be less painful are not given sufficient pain relief. MedWire News (U.K.) (2/15)
Diabetic neuropathy may respond to progressive exercise training
Research on rats by Taiwanese scientists indicates that progressive exercise training may help reduce diabetic neuropathic pain. Authors of the study, published in the journal Anesthesia & Analgesia, hope their work may lead to new non-pharmacologic treatments to manage painful diabetic neuropathy. PhysiciansBriefing.com/HealthDay News (2/11)
Other News
Policy & Trends
Lawmakers ask FDA for timeline on reclassifying hydrocodone
Seven U.S. lawmakers asked the FDA to create a time frame for reclassifying hydrocodone drugs from Schedule III to Schedule II. The change would mean patients would need a physician's written prescription to be able to purchase the medications. The Hill/RegWatch blog (2/15), Pharmalot.com/Pharma Blog (2/15)
Mass. hearings seek input on regulating medical marijuana
Public hearings are being held throughout Massachusetts to give officials with the state's Department of Public Health input on regulating medical marijuana to treat pain and other symptoms. While cancer patients support using marijuana to fight pain, the American Cancer Society does not support inhaled marijuana and says more studies are needed. WGBH-TV/WGBH-AM/FM (Boston) (2/20)
Other News
APS News
APS Annual Scientific Meeting: Register now and receive $100 off your registration!
The 32nd Annual Scientific Meeting of the American Pain Society will be held May 8-11 in New Orleans. This year's meeting provides attendees with a unique forum for sharing advances and standards in evidence-based pain research and treatment by colleagues from all disciplines in pain. APS offers continuing education credit for physicians, psychologists, nurses and pharmacists. Additional highlights include 30 symposia sessions, 3 in-depth workshops and 17 special interest group meetings. Learn more.
Request for Data Blitz submissions
APS is now accepting submissions for the Clinical and Basic Science Data Blitz to be held on Wednesday, May 8, in New Orleans as part of the 32nd Annual Scientific Meeting. Authors are encouraged to submit innovative and compelling clinical and basic science research for presentation. Submissions from doctoral students and postdoctoral fellows are encouraged. Submission deadline is Monday, March 18. Learn more.
We must travel in the direction of our fear."
-- John Berryman,
American poet and scholar
Learn more about APS ->About APS | Membership | Education | Resources | Journal of Pain
Subscriber Tools
Please contact one of our specialists for advertising opportunities, editorial inquiries, job placements, or any other questions.
Advertising:  Aaron Kern
  P: 202.407.7866

Download the SmartBrief App  iTunes / Android
iTunes  Android
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2013 SmartBrief, Inc.®
Privacy policy |  Legal Information